Literature DB >> 22252565

An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer.

Ning Shao, Shidai Jin, Wei Zhu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252565     DOI: 10.1097/JTO.0b013e31823c5a23

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  9 in total

Review 1.  SEOM clinical guidelines for the treatment of small-cell lung cancer 2013.

Authors:  M Dómine Gómez; T Morán Bueno; A Artal Cortés; J Remon Masip; P Lianes Barragán
Journal:  Clin Transl Oncol       Date:  2013-09-05       Impact factor: 3.405

Review 2.  Progress and challenges in the treatment of small cell lung cancer.

Authors:  Alfredo Tartarone; Pasqualina Giordano; Rosa Lerose; Maria Grazia Rodriquenz; Raffaele Conca; Michele Aieta
Journal:  Med Oncol       Date:  2017-04-29       Impact factor: 3.064

Review 3.  Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?

Authors:  Luca Paglialunga; Zena Salih; Biagio Ricciuti; Raffaele Califano
Journal:  ESMO Open       Date:  2016-08-05

4.  Comparing the adverse effects of platinum in combination with etoposide or irinotecan in previously untreated small-cell lung cancer patients with extensive disease: A network meta-analyses.

Authors:  Yujie Chen; Lingxiao Chen; Diansheng Zhong
Journal:  Thorac Cancer       Date:  2017-03-06       Impact factor: 3.500

5.  Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trial.

Authors:  Gyeong-Won Lee; Se-Il Go; Dong-Wan Kim; Hoon-Gu Kim; Joo-Hang Kim; Ho Jung An; Joung Soon Jang; Bong-Seog Kim; Seokyung Hahn; Dae Seog Heo
Journal:  Thorac Cancer       Date:  2019-11-10       Impact factor: 3.500

6.  Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis.

Authors:  Hao Chen; Nobuyuki Horita; Kentaro Ito; Hideyuki Nagakura; Yu Hara; Nobuaki Kobayash; Masaki Yamamoto; Makoto Kudo; Takeshi Kaneko
Journal:  Ther Adv Med Oncol       Date:  2020-10-17       Impact factor: 8.168

7.  Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.

Authors:  Akihiro Ohmoto; Masami Suzuki; Erina Takai; Hirofumi Rokutan; Yuko Fujiwara; Chigusa Morizane; Kazuyoshi Yanagihara; Tatsuhiro Shibata; Shinichi Yachida
Journal:  Oncotarget       Date:  2018-04-20

8.  [First-line Chemotherapy for Extensive-disease Small Cell Lung Cancer: 
A Network Meta-analysis].

Authors:  Yujie Chen; Lingxiao Chen; Diansheng Zhong; Jing Wang; Lina Peng; Xin Feng
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-04-20

9.  A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer.

Authors:  Thierry Berghmans; Arnaud Scherpereel; Anne-Pascale Meert; Vicente Giner; Jacques Lecomte; Jean-Jacques Lafitte; Nathalie Leclercq; Marianne Paesmans; Jean-Paul Sculier
Journal:  Front Oncol       Date:  2017-09-19       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.